Author

Wai-Key Seto

Department of Medicine, The University of Hong Kong, Hong Kong - Cited by 12,641 - Gastroenterology and Hepatology

Biography

Prof. Wai-Kay Seto graduated from the University of Hong Kong in 2003 and received his Fellowship in Gastroenterology and Hepatology in 2010 from the Hong Kong College of Physicians. He received his Doctor of Medicine from the University of Hong Kong in 2012. He is currently a Clinical Professor in the Department of Medicine and Principal Investigator of the State Key Laboratory of Liver Disease, the University of Hong Kong, Hong Kong. He is also Assistant Hospital Chief Executive (Research) and Medical Director, Clinical Trials Center of the University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Title
Cited by
Year
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
KS Cheung, CH Mok, X Mao, R Zhang, IFN Hung, WK Seto, MF YuenClinical and Molecular Hepatology 28 (4), 890, 2022202
13
2022
Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes
LY Mak, RWH Hui, CH Lee, XH Mao, KS Cheung, DKH Wong, DTW Lui, ...Hepatology, 2023202
11
2023
Effect of antiviral treatment on hepatitis B virus integration and hepatocyte clonal expansion
N Chow, D Wong, CL Lai, LY Mak, J Fung, HT Ma, MW Lei, WK Seto, ...Clinical Infectious Diseases 76 (3), e801-e809, 2023202
10
2023
Steatosis, HBV‐related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta‐analysis
X Mao, KS Cheung, C Peng, LY Mak, HM Cheng, J Fung, N Peleg, ...Hepatology, 2022202
9
2022
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos (t …
LY Mak, D Wong, A Kuchta, M Hilfiker, A Hamilton, N Chow, XH Mao, ...Clinical and Molecular Hepatology 29 (1), 14, 2023202
6
2023
The role of different viral biomarkers on the management of chronic hepatitis B
LY Mak, RWH Hui, J Fung, WK Seto, MF YuenClinical and Molecular Hepatology 29 (2), 263, 2023202
4
2023
HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos (t) ide analogue in CHB
HBV pgRNA and HBcrAg reductions at week predict favourable HBsAg response upon long-term nucleos (t) ide analogue in CHBLY Mak, D Wong, A Kuchta, M Hilfiker, A Hamilton, N Chow, X Mao, ...Clin Mol Hepatol, 2022202
4
2022
Statins associate with lower risk of biliary tract cancers: A systematic review and meta‐analysis
KS Cheung, YWM Yeung, WS Wong, B Li, WK Seto, WK LeungCancer Medicine 12 (1), 557-568, 2023202
4
2023
New strategies for the treatment of chronic hepatitis B
LY Mak, KS Cheung, J Fung, WK Seto, MF YuenTrends in Molecular Medicine 28 (9), 742-757, 2022202
3
2022
Novel combination strategies with investigational agents for functional cure of chronic hepatitis B infection
RWH Hui, LY Mak, KS Cheung, J Fung, WK Seto, MF YuenCurrent Hepatology Reports 21 (4), 59-67, 2022202
3
2022
Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide
L Zhang, H Liu, Z Zou, S Su, JJ Ong, F Ji, F Cui, P Chan, Q Ning, R Li, ...The Lancet Regional Health–Western Pacific, 20220
3
2023
Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
RWH Hui, LY Mak, TT Cheung, VHF Lee, WK Seto, MF YuenClinical and Molecular Hepatology 29 (2), 217, 20220
3
2023
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: the multicentre, prospective CAP‐Asia study
YW Leow, WK Chan, GBB Goh, VWS Wong, JG Fan, YS Kim, SU Kim, ...Journal of Viral Hepatitis 0 (4), 19-26, 20220
3
2023
Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B
HSJ Choi, G Hirode, CH Chen, TH Su, WK Seto, S Van Hees, ...Clinical Gastroenterology and Hepatology 21 (6), 151-1522. e4, 20220
3
2023
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly …
DKH Wong, T Inoue, LY Mak, RWH Hui, J Fung, KS Cheung, WK Seto, ...Journal of Clinical Virology 160, 105375, 030
2
2023
Long-term hepatitis B surface antigen profile and seroclearance after severe acute flares of chronic hepatitis B
KY Hui, J Fung, KS Cheung, LY Mak, WK Seto, MF YuenGut and Liver 17 (), 80, 030
2
2023
Role of Serum M2BPGi levels in predicting persistence of advanced fibrosis in chronic hepatitis B virus infection
Role of Serum MBPGi levels in predicting persistence of advanced fibrosis in chronic hepatitis B virus infectionLY Mak, DKH Wong, KS Cheung, RWH Hui, F Liu, J Fung, WK Seto, ...Digestive Diseases and Sciences 67 (11), 517-5136, 0
2
2022
Association between antibiotic consumption and colon and rectal cancer development in older individuals: A territory‐wide study
KS Cheung, EW Chan, A Tam, IOL Wong, WK Seto, IFN Hung, ICK Wong, ...Cancer Medicine 11 (0), 3863-387, 0
2
2022
Screening strategy for non-alcoholic fatty liver disease
S Zhang, LY Mak, MF Yuen, WK SetoClinical and Molecular Hepatology 29 (Suppl), S03, 2023202
1
2023
Comprehensive Guide to Hepatitis Advances
WKW Seto, M EslamElsevier, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=20RXJoQAAAAJ&hl=en

Cited by
Citations 12641
h-index 57
i10-index 183
Recommended Journals
Open Access Journals